Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Capstone Holding Corp. Director's Dealing 2013

Aug 1, 2013

35323_dirs_2013-08-01_07fe4e4d-ac06-4d37-a3ed-d9c1d8a1f7eb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2013-07-30

Reporting Person: MILLER LLOYD I III (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-07-30 Common Stock P 1139000 $0.20 Acquired 5851468 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 472792 Indirect
Common Stock 90344 Indirect
Common Stock 545462 Indirect
Common Stock 95756 Indirect
Common Stock 724100 Indirect
Common Stock 58967 Direct

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.

F2: On December 5, 2012, 545,462 securities held by Milgrat (Q8) were transferred to Trust C. Such transaction only effected a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in such securities and was exempt from Section 16 of the Securities Exchange Act of 1934 pursuant to Rule 16a-13.